Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Teva Pharmaceutical Industries Ltd (TEVA) AI Forecast

Our AI detected a significant signal for Teva Pharmaceutical Industries Ltd. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$TEVA Bullish Signal Full forecast available
Sign Up Free

Teva Pharmaceutical Industries Ltd (TEVA) Stock Forecast 2025

Teva Pharmaceutical Industries Ltd (TEVA) AI Stock Price Forecast & Investment Analysis

Teva Pharmaceutical Industries Ltd Stock Price Chart and Technical Analysis

Loading chart...

Teva Pharmaceutical Industries Ltd (TEVA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Teva Pharmaceutical Industries Ltd's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 12, 2026, 5:53 a.m. (UTC)

Teva Pharmaceutical Industries Ltd Investment Summary

When evaluating whether Teva Pharmaceutical Industries Ltd (TEVA) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Teva Pharmaceutical Industries Ltd (TEVA) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $35 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Teva Pharmaceutical Industries Ltd's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Teva Pharmaceutical Industries Ltd along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Teva Pharmaceutical Industries Ltd is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Teva Pharmaceutical Industries Ltd

Sign Up Free
Corporate Identity

Teva Pharmaceutical Industries Ltd (Stock Symbol: TEVA) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Teva Pharmaceutical Industries Ltd's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Teva Pharmaceutical Industries Ltd...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Teva Pharmaceutical Industries Ltd...

Unlock Full Company Profile

Get complete details about Teva Pharmaceutical Industries Ltd

Sign Up Free
Revenue & Growth Analysis

Teva Pharmaceutical Industries Ltd generates annual revenues of $17 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Teva Pharmaceutical Industries Ltd...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Teva Pharmaceutical Industries Ltd...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Teva Pharmaceutical Industries Ltd...

Unlock Financial Analysis

Get complete financial metrics for Teva Pharmaceutical Industries Ltd

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Teva Pharmaceutical Industries Ltd's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Teva Pharmaceutical Industries Ltd strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Teva Pharmaceutical Industries Ltd competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Margin & Pricing Power Analysis

The company maintains a 49.9% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.

Operating margin of 17.1% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This healthy operating margin shows balanced investment in growth functions while maintaining reasonable profitability.

Financial Strength & Leverage

Teva Pharmaceutical Industries Ltd (TEVA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Teva Pharmaceutical Industries Ltd stock analysis.

Deep dive into Teva Pharmaceutical Industries Ltd's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Teva Pharmaceutical Industries Ltd stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Teva Pharmaceutical Industries Ltd: With a P/E ratio of 25.08, the market highly values future growth prospects.

P/E Ratio 25.08x
P/B Ratio 4.47x
Market Cap $35.36B
Dividend Yield 17.69%
EPS $-0.15
Book Value/Share $6.88
Revenue/Share $15.01
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Teva Pharmaceutical Industries Ltd converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Teva Pharmaceutical Industries Ltd:

Gross Margin 49.9%
Operating Margin 17.1%
Net Margin 14.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Teva Pharmaceutical Industries Ltd's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Teva Pharmaceutical Industries Ltd:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Teva Pharmaceutical Industries Ltd's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Teva Pharmaceutical Industries Ltd:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Teva Pharmaceutical Industries Ltd uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Teva Pharmaceutical Industries Ltd:

Understanding Financial Statement Data

What these metrics mean: Key figures from Teva Pharmaceutical Industries Ltd's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Teva Pharmaceutical Industries Ltd: With annual revenue of $17258M, Teva Pharmaceutical Industries Ltd operates at significant scale.

Income Statement
Total Revenue $17.26B
Operating Income $2.15B
Net Income $1.80B
R&D Expense $54M
Cost of Goods Sold $6.30B
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Payout Ratio 3.2%
Shares Outstanding 1150M
Growth Metrics (YoY)
EPS Growth 6.6%

Latest Teva Pharmaceutical Industries Ltd Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Teva Pharmaceutical Industries Ltd (TEVA) stock price and investment outlook.

📰 We are currently updating our news feed for Teva Pharmaceutical Industries Ltd. Check back soon for the latest market analysis and company updates.

Teva Pharmaceutical Industries Ltd Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Teva Pharmaceutical Industries Ltd against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $113M x 0.9x
Abbvie Inc. ABBV ██% $402.77B 95.3x 283.6x
Abcellera Biologics Inc. ABCL ██% $1.10B -5.3x 1.1x
Abeona Therapeutics Inc. ABEO ██% $263M 3.2x 1.5x
Abbott Laboratories ABT ██% $191.95B 29.4x 3.7x
Arbutus Biopharma Corp ABUS ██% $906M -8.3x 11.7x
Abvc Biopharma, Inc. ABVC ██% $36M -0.3x 3.2x
Abivax S.A. ABVX ██% $8.88B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.74B 9.6x 3.1x
Adicet Bio, Inc. ACET ██% $72M -0.4x 0.7x
Aclaris Therapeutics, Inc. ACRS ██% $434M -4.5x 4.2x
Acrivon Therapeutics, Inc. ACRV ██% $51M -2.8x 0.4x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $7M x 8.7x
Acurx Pharmaceuticals, Inc. ACXP ██% $15M -0.8x 4.2x
Adagene Inc. ADAG ██% $167M x 4.4x
Adc Therapeutics Sa ADCT ██% $614M -9.2x -1.3x
Adial Pharmaceuticals, Inc. ADIL ██% $2M -0.1x 0.4x
Aditxt, Inc. ADTX ██% $590K 0.0x 0.1x
Addex Therapeutics Ltd. ADXN ██% $9M x x
Aeon Biopharma, Inc. AEON ██% $29M 6.4x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.64B 3.7x 1.4x
Ainos, Inc. AIMD ██% $11M -0.4x 1.1x
Akebia Therapeutics, Inc. AKBA ██% $372M -5.4x 11.4x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $12M -2.0x 0.5x
Aldeyra Therapeutics, Inc. ALDX ██% $297M -5.1x 6.7x
Alkermes Plc. ALKS ██% $4.60B 19.0x 2.5x
Allarity Therapeutics, Inc. ALLR ██% $20M -0.2x 1.7x
Alumis Inc. ALMS ██% $3.28B x 8.5x
Alnylam Pharmaceuticals, Inc. ALNY ██% $42.42B 135.2x 53.8x
Altimmune, Inc. ALT ██% $476M -5.7x 2.1x
Alx Oncology Holdings Inc ALXO ██% $282M -0.4x 10.9x
Alzamend Neuro, Inc. ALZN ██% $8M -0.1x 1.7x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.64B -1.5x 5.4x
Amphastar Pharmaceuticals, Inc. AMPH ██% $857M 8.7x 1.9x
Amarin Corp Plc\Uk AMRN ██% $340M -4.5x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $3.98B 55.3x 201.4x
Anaptysbio, Inc ANAB ██% $1.81B -2.5x 48.7x
Anebulo Pharmaceuticals, Inc. ANEB ██% $19M -4.3x 2.4x
Ani Pharmaceuticals Inc ANIP ██% $1.72B 21.9x 3.2x
Anixa Biosciences Inc ANIX ██% $98M -15.0x 6.5x
Annexon, Inc. ANNX ██% $896M -4.1x 5.6x
Alto Neuroscience, Inc. ANRO ██% $716M x 6.4x
An2 Therapeutics, Inc. ANTX ██% $78M x 1.3x
Annovis Bio, Inc. ANVS ██% $66M -1.0x 5.0x
Apollomics Inc. APLM ██% $44M x x
Apellis Pharmaceuticals, Inc. APLS ██% $2.54B 113.5x 6.9x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $9M -1.2x 0.8x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $17M x 2.1x
Aptevo Therapeutics Inc. APVO ██% $7M -0.1x 0.4x
Aquestive Therapeutics, Inc. AQST ██% $515M -10.7x 51.1x
Arcturus Therapeutics Holdings Inc. ARCT ██% $202M -7.0x 0.9x
Ardelyx, Inc. ARDX ██% $1.46B -21.3x 8.8x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.95B -6.6x 15.6x
Artelo Biosciences, Inc. ARTL ██% $3M -0.7x 4.5x
Arvinas, Inc. ARVN ██% $856M -4.8x 2.0x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $7.98B 39.5x 14.0x
Aspire Biopharma Holdings, Inc. ASBP ██% $6M x x
Assembly Biosciences, Inc. ASMB ██% $462M -1.5x 2.5x
Ascendis Pharma A/S ASND ██% $14.10B x x
Assertio Holdings, Inc. ASRT ██% $74M -0.2x 0.7x
Atai Beckley N.V. ATAI ██% $1.47B -4.4x 9.2x
Alterity Therapeutics Ltd ATHE ██% $68M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $37M -4.1x 2.7x
Atossa Therapeutics, Inc. ATOS ██% $41M -6.2x 0.8x
Avenue Therapeutics, Inc. ATXI ██% $880K -9.5x 0.3x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $1.96B 6.8x 3.4x
Arrivent Biopharma, Inc. AVBP ██% $1.04B x 3.4x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $477M -1.5x 1.7x
Avalo Therapeutics, Inc. AVTX ██% $313M -0.1x 3.4x
Axim Biotechnologies, Inc. AXIM ██% $4M x 0.8x
Axsome Therapeutics, Inc. AXSM ██% $8.46B -19.9x 95.9x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $2M -0.2x 0.5x
Bridgebio Pharma, Inc. BBIO ██% $14.48B -11.6x -5.4x
Bicara Therapeutics Inc. BCAX ██% $1.29B x 3.2x
Briacell Therapeutics Corp. BCTX ██% $31M -1.7x 1.0x
Bicycle Therapeutics Plc BCYC ██% $367M -6.0x 0.6x
Bioadaptives, Inc. BDPT ██% $130K x 11.0x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $6M -2.9x 3.3x
Biofrontera Inc. BFRI ██% $10M -0.1x 21.0x
Bausch Health Companies Inc. BHC ██% $1.99B 12.7x 3.7x
Bioharvest Sciences Inc. BHST ██% $96M x 71.9x
Biohaven Ltd. BHVN ██% $1.57B -4.6x 30.2x
Bioage Labs, Inc. BIOA ██% $838M x 3.0x
Bio Essence Corp BIOE ██% $2M x x
Biovie Inc. BIVI ██% $11M -0.6x 0.6x
Bioxytran, Inc BIXT ██% $4M x 7.5x
Biolinerx Ltd. BLRX ██% $12M x x
Belite Bio, Inc BLTE ██% $6.50B x 71.9x
Biomea Fusion, Inc. BMEA ██% $98M -1.6x 6.3x
Biomarin Pharmaceutical Inc BMRN ██% $11.75B 33.7x 1.9x
Bristol Myers Squibb Co BMY ██% $122.00B 17.3x 6.6x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $421M -0.6x 2.3x
Boundless Bio, Inc. BOLD ██% $26M -15.1x 0.3x
Bolt Biotherapeutics, Inc. BOLT ██% $8M -0.3x 0.3x
Bio-Path Holdings, Inc. BPTH ██% $590K 0.0x 3.8x
Bioquest Corp BQST ██% $15M x 3.0x
Barinthus Biotherapeutics Plc. BRNS ██% $24M -0.6x 0.3x
Bespoke Extracts, Inc. BSPK ██% $3M x 181.5x
Bioxcel Therapeutics, Inc. BTAI ██% $31M -0.1x 5.4x
Beyondspring Inc. BYSI ██% $58M 51.7x 1.1x
Calcimedica, Inc. CALC ██% $11M 0.4x 1.8x
Camp4 Therapeutics Corp CAMP ██% $291M -0.1x 6.1x
Can-Fite Biopharma Ltd. CANF ██% $5M x 1.3x
Capricor Therapeutics, Inc. CAPR ██% $1.52B x 18.1x
Carisma Therapeutics Inc. CARM ██% $2M 0.2x 0.0x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $595M -2.8x 2.5x
Crescent Biopharma, Inc. CBIO ██% $327M -6.5x 1.6x
Cdt Equity Inc. CDT ██% $2M -0.7x 0.5x
Cingulate Inc. CING ██% $93M -0.6x 26.8x
Cell Source, Inc. CLCS ██% $42M x 3742.2x
Clene Inc. CLNN ██% $58M -7.3x 13.7x
Cellectar Biosciences, Inc. CLRB ██% $13M x 1.5x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Climb Bio, Inc. CLYM ██% $488M -1.4x 2.8x
Chemomab Therapeutics Ltd. CMMB ██% $12M 10.9x 1.2x
Clearmind Medicine Inc. CMND ██% $2M x x
Compass Pathways Plc CMPS ██% $782M 0.0x 20.8x
Cnbx Pharmaceuticals Inc. CNBX ██% $90K x 0.1x
Cns Pharmaceuticals, Inc. CNSP ██% $2M 0.0x 0.2x
Centessa Pharmaceuticals Plc CNTA ██% $3.79B -11.0x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $168M x 3.0x
Context Therapeutics Inc. CNTX ██% $291M -1.5x 4.0x
Cocrystal Pharma, Inc. COCP ██% $14M -1.0x 1.8x
Cogent Biosciences, Inc. COGT ██% $5.81B -3.7x 9.1x
Collegium Pharmaceutical, Inc COLL ██% $1.32B 21.0x 4.4x
Corcept Therapeutics Inc CORT ██% $3.58B 35.9x 5.5x
Coya Therapeutics, Inc. COYA ██% $104M -6.8x 3.8x
China Pharma Holdings, Inc. CPHI ██% $3M -0.2x 0.4x
Cumberland Pharmaceuticals Inc CPIX ██% $46M -4.5x 1.9x
Cannapharmarx, Inc. CPMD ██% $3M x 1.9x
Catalyst Pharmaceuticals, Inc. CPRX ██% $2.99B 14.0x 3.1x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $184M -2.0x 1.3x
Cormedix Inc. CRMD ██% $530M 3.3x 1.3x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.53B -15.9x 3.6x
Cervomed Inc. CRVO ██% $41M -0.7x 1.6x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.42B -13.7x 19.7x
Cytomx Therapeutics, Inc. CTMX ██% $827M 29.5x 7.7x
Contineum Therapeutics, Inc. CTNM ██% $547M x 2.1x
Citius Oncology, Inc. CTOR ██% $79M 3.9x 1.4x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Citius Pharmaceuticals, Inc. CTXR ██% $20M -5.3x 0.3x
Cue Biopharma, Inc. CUE ██% $30M -1.2x 2.2x
Cadrenal Therapeutics, Inc. CVKD ██% $18M -11.1x 6.7x
Cv Sciences, Inc. CVSI ██% $9M x 6.0x
Cyclerion Therapeutics, Inc. CYCN ██% $5M -5.2x 0.6x
Cytodyn Inc. CYDY ██% $304M 86.7x 109.8x
Cryoport, Inc. CYRX ██% $399M 5.1x 0.8x
Cytokinetics Inc CYTK ██% $7.84B -9.4x 72.2x
Dare Bioscience, Inc. DARE ██% $21M 2.9x 7.5x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.19B -8.9x 5.0x
Journey Medical Corp DERM ██% $272M 24.1x 10.5x
Diamedica Therapeutics Inc. DMAC ██% $402M -4.2x 7.8x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $3.71B -3.2x 7.5x
Dermata Therapeutics, Inc. DRMA ██% $4M -0.2x 1.0x
Bright Minds Biosciences Inc. DRUG ██% $742M x x
Design Therapeutics, Inc. DSGN ██% $605M -7.6x 2.9x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $90M -2.9x 12.4x
Dyne Therapeutics, Inc. DYN ██% $3.26B -7.8x 3.4x
Emergent Biosolutions Inc. EBS ██% $426M 8.1x 0.8x
Edesa Biotech, Inc. EDSA ██% $58M -1.3x 4.1x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $2M -8.2x 0.3x
Elanco Animal Health Inc ELAN ██% $11.76B 341.6x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $231M x 6.5x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $430M 16.3x 5.4x
Elicio Therapeutics, Inc. ELTX ██% $203M -1.9x 53.3x
Enliven Therapeutics, Inc. ELVN ██% $1.82B -13.3x 4.0x
Emmaus Life Sciences, Inc. EMMA ██% $930K x 0.2x
Enlivex Ltd. ENLV ██% $266M x 14.0x
Ensysce Biosciences, Inc. ENSC ██% $2M x 1.4x
Enanta Pharmaceuticals Inc ENTA ██% $411M -1.3x 3.3x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $3M -0.1x 0.8x
Evolus, Inc. EOLS ██% $343M -13.1x 62.2x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Equillium, Inc. EQ ██% $121M -3.2x 3.9x
Erasca, Inc. ERAS ██% $3.88B -3.1x 11.1x
Ernexa Therapeutics Inc. ERNA ██% $8M x 2.3x
Esperion Therapeutics, Inc. ESPR ██% $801M -4.2x 89.4x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $467M -66.2x 20.2x
Earth Science Tech, Inc. ETST ██% $35M 16.8x 6.1x
Evofem Biosciences, Inc. EVFM ██% $1M -0.1x 0.1x
Edgewise Therapeutics, Inc. EWTX ██% $3.11B -19.7x 6.0x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $104M 26.1x 1.9x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $27M x 4.4x
Forte Biosciences, Inc. FBRX ██% $354M -11.5x 4.2x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $310M -3.3x 2771.6x
Amicus Therapeutics, Inc. FOLD ██% $4.46B -8.5x 16.3x
Fulcrum Therapeutics, Inc. FULC ██% $533M -36.1x 1.5x
Galectin Therapeutics Inc GALT ██% $197M -2.4x 220.9x
Gain Therapeutics, Inc. GANX ██% $102M -1.4x 17.2x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $230K x x
Geron Corp GERN ██% $1.04B -11.9x 4.6x
Gh Research Plc GHRS ██% $938M x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.2x
Galapagos Nv GLPG ██% $2.22B x x
Greenwich Lifesciences, Inc. GLSI ██% $382M -17.2x 175.0x
Galecto, Inc. GLTO ██% $1.54B -2.5x 191.9x
Genelux Corp GNLX ██% $125M -2.8x 6.7x
Genprex, Inc. GNPX ██% $5M -3.2x 5.9x
Gossamer Bio, Inc. GOSS ██% $117M -3.2x 4.0x
Geovax Labs, Inc. GOVX ██% $3M x 0.6x
Structure Therapeutics Inc. GPCR ██% $4.12B -44.0x 2.7x
Grace Therapeutics, Inc. GRCE ██% $61M -3.9x 0.9x
Gri Bio, Inc. GRI ██% $4M -0.1x 0.7x
Galera Therapeutics, Inc. GRTX ██% $4M -0.3x 0.6x
Gsk Plc GSK ██% $110.81B x x
Gt Biopharma, Inc. GTBP ██% $11M x 1.9x
Gyre Therapeutics, Inc. GYRE ██% $738M 62.6x 7.2x
Hutchmed (China) Ltd HCM ██% $2.51B x 2.0x
Hcw Biologics Inc. HCWB ██% $3M x 0.4x
Hepion Pharmaceuticals, Inc. HEPA ██% $670K -0.1x 0.2x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $13M -1.0x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $15M -0.5x 1.9x
Werewolf Therapeutics, Inc. HOWL ██% $28M -1.3x 1.0x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.66B 10.5x 1.9x
Heron Therapeutics, Inc. /De/ HRTX ██% $186M -6.4x 13.0x
Hst Global, Inc. HSTC ██% $35M x 28.3x
Tuhura Biosciences, Inc./Nv HURA ██% $92M x 5.5x
Ibio, Inc. IBIO ██% $82M -0.4x 1.5x
Impact Biomedical Inc. IBO ██% $64M x 16.6x
Ideaya Biosciences, Inc. IDYA ██% $2.91B -12.2x 2.9x
Inflarx N.V. IFRX ██% $63M x x
Igc Pharma, Inc. IGC ██% $27M -4.6x 3.3x
Immutep Ltd IMMP ██% $406M x x
Immix Biopharma, Inc. IMMX ██% $551M x 41.6x
Immunome Inc. IMNM ██% $2.47B -2.4x 3.9x
Imunon, Inc. IMNN ██% $11M -0.5x 2.6x
Immuron Ltd IMRN ██% $7M x x
Immuneering Corp IMRX ██% $363M -0.8x 1.7x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $168M -0.8x 16.0x
Integrated Biopharma Inc INBP ██% $9M 14.8x 0.5x
Indaptus Therapeutics, Inc. INDP ██% $4M -0.6x 0.9x
Indivior Pharmaceuticals, Inc. INDV ██% $4.17B 19.8x x
Inmed Pharmaceuticals Inc. INM ██% $2M -51.8x 0.2x
Inovio Pharmaceuticals, Inc. INO ██% $119M -0.6x 4.2x
Insmed Inc INSM ██% $30.82B -14.0x 41.7x
Inhibitor Therapeutics, Inc. INTI ██% $15M x 4398.1x
Innoviva, Inc. INVA ██% $1.67B 6.2x 1.4x
Io Biotech, Inc. IOBT ██% $24M -0.7x 26.7x
Ionis Pharmaceuticals Inc IONS ██% $13.25B -14.6x 27.1x
Opus Genetics, Inc. IRD ██% $268M -2.0x 45.0x
Disc Medicine, Inc. IRON ██% $2.51B -18.4x 3.4x
Ironwood Pharmaceuticals Inc IRWD ██% $558M 23.2x 0.8x
International Stem Cell Corp ISCO ██% $1M x 0.4x
Iterum Therapeutics Plc ITRM ██% $10M -0.8x 2.8x
Inventiva S.A. IVA ██% $1.37B x x
Incannex Healthcare Inc. IXHL ██% $60M x 0.8x
Jaguar Health, Inc. JAGX ██% $4M -0.2x 0.7x
Janux Therapeutics, Inc. JANX ██% $850M -63.7x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $11.67B 14.3x 2.7x
Jade Biosciences, Inc. JBIO ██% $714M x 2.2x
Johnson & Johnson JNJ ██% $586.71B 21.9x 7.4x
Jupiter Neurosciences, Inc. JUNS ██% $14M x 244.3x
Kala Bio, Inc. KALA ██% $268M -0.5x 46.9x
Kalvista Pharmaceuticals, Inc. KALV ██% $932M -2.6x 54.8x
Kairos Pharma, Ltd. KAPA ██% $13M x 1.7x
Kaya Holdings, Inc. KAYS ██% $28M x x
Kamada Ltd KMDA ██% $515M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.49B 59.1x 6.2x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $151M -0.6x 3.0x
Keros Therapeutics, Inc. KROS ██% $353M 4.1x 1.2x
Korro Bio, Inc. KRRO ██% $105M -7.9x 1.6x
Pasithea Therapeutics Corp. KTTA ██% $19M -73.5x 1.6x
Kura Oncology, Inc. KURA ██% $814M -4.5x 4.7x
Kezar Life Sciences, Inc. KZR ██% $51M -3.2x 0.6x
Legend Biotech Corp LEGN ██% $3.61B x x
Lexaria Bioscience Corp. LEXX ██% $18M -29.3x 3.7x
Lifecore Biomedical, Inc. \De\ LFCR ██% $261M x 195.2x
Lifevantage Corp LFVN ██% $66M 8.5x 2.0x
Ligand Pharmaceuticals Inc LGND ██% $4.20B 33.7x 4.1x
Longeveron Inc. LGVN ██% $19M -0.5x 1.9x
Lianbio LIANY ██% $12M x 0.1x
Lftd Partners Inc. LIFD ██% $4M 56.1x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $730K -3.3x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $22M -0.9x 4.6x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $898.51B 43.5x 33.9x
Lipocine Inc. LPCN ██% $45M -2.6x 3.1x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $3.39B -7.2x 75.7x
Larimar Therapeutics, Inc. LRMR ██% $581M -0.8x 4.2x
Lisata Therapeutics, Inc. LSTA ██% $44M -1.0x 2.5x
Lantern Pharma Inc. LTRN ██% $30M -2.4x 3.2x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $703M -1.2x 6.5x
Lyell Immunopharma, Inc. LYEL ██% $433M -1.1x 1.3x
Maia Biotechnology, Inc. MAIA ██% $88M -1.4x 2111.6x
Mustang Bio, Inc. MBIO ██% $7M -0.1x 0.7x
Moleculin Biotech, Inc. MBRX ██% $6M -2.3x 152.5x
Mbx Biosciences, Inc. MBX ██% $1.37B x 3.5x
Seres Therapeutics, Inc. MCRB ██% $80M 14.8x 1.8x
Medicus Pharma Ltd. MDCX ██% $10M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $9.89B -5.7x 16.4x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $141M -2.1x 2.1x
Mira Pharmaceuticals, Inc. MIRA ██% $51M -1.6x 6.8x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.49B -20.0x 17.4x
Milestone Pharmaceuticals Inc. MIST ██% $152M -2.0x 7.4x
Moonlake Immunotherapeutics MLTX ██% $1.32B -50.8x 4.3x
Mineralys Therapeutics, Inc. MLYS ██% $2.25B -4.5x 3.9x
Mannkind Corp MNKD ██% $803M 137.0x 45.8x
Medicinova Inc MNOV ██% $69M -7.1x 1.7x
Monopar Therapeutics MNPR ██% $390M -3.0x 2.8x
Mereo Biopharma Group Plc MREO ██% $64M x 1.4x
Merck & Co., Inc. MRK ██% $292.96B 16.1x 5.6x
Marker Therapeutics, Inc. MRKR ██% $24M -0.6x 1.3x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.29B -5.6x 6.1x
Matinas Biopharma Holdings, Inc. MTNB ██% $4M -1.7x 0.6x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $5M -0.5x 0.8x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $10M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.42B x 5.0x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $439M 22.5x 2.7x
Novabay Pharmaceuticals, Inc. NBY ██% $33M 7.4x 29.7x
Nucana Plc NCNA ██% $8M x x
Minerva Neurosciences, Inc. NERV ██% $344M -0.8x 43.1x
Neuphoria Therapeutics Inc. NEUP ██% $25M x 0.8x
Neurogene Inc. NGNE ██% $341M -7.3x 1.3x
Nika Pharmaceuticals, Inc NIKA ██% $786M x 192879.0x
Nektar Therapeutics NKTR ██% $2.02B -1.2x 23.7x
Nkarta, Inc. NKTX ██% $190M -1.3x 0.6x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $21M -2.1x 1.9x
Nurix Therapeutics, Inc. NRIX ██% $1.54B -7.4x 2.9x
Neurosense Therapeutics Ltd. NRSN ██% $29M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $58M -0.6x 7.8x
Neonc Technologies Holdings, Inc. NTHI ██% $230M x x
Nuvation Bio Inc. NUVB ██% $1.58B -1.2x 5.2x
Nuvalent, Inc. NUVL ██% $7.23B -30.9x 5.8x
Nuvectis Pharma, Inc. NVCT ██% $248M -3.9x 13.5x
Novartis Ag NVS ██% $305.53B x x
Northwest Biotherapeutics Inc NWBO ██% $349M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $45M -0.5x 1.3x
Ocean Biomedical, Inc. OCEA ██% $70K -0.3x 0.0x
Ocular Therapeutix, Inc OCUL ██% $2.13B -8.2x 3.3x
Oragenics Inc OGEN ██% $4M -0.1x 0.4x
Organigram Global Inc. OGI ██% $195M x x
Organon & Co. OGN ██% $1.67B 8.9x 2.2x
Onkure Therapeutics, Inc. OKUR ██% $50M -6.9x 0.8x
Olema Pharmaceuticals, Inc. OLMA ██% $1.73B -4.0x 5.6x
Omeros Corp OMER ██% $811M -4.2x 39.6x
Beone Medicines Ltd. ONC ██% $34.85B 121.5x 8.0x
Onconetix, Inc. ONCO ██% $760K -0.3x 0.0x
Oncolytics Biotech Inc ONCY ██% $110M x x
Opko Health, Inc. OPK ██% $894M -3.5x 0.7x
Organogenesis Holdings Inc. ORGO ██% $343M 9.3x 1.1x
Orgenesis Inc. ORGS ██% $3M 0.9x 0.2x
Oric Pharmaceuticals, Inc. ORIC ██% $1.42B -4.2x 3.7x
Oruka Therapeutics, Inc. ORKA ██% $1.62B x 3.3x
Oramed Pharmaceuticals Inc. ORMP ██% $135M 3.1x 0.7x
Os Therapies Inc OSTX ██% $52M x 14.4x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 1.9x
Ovid Therapeutics Inc. OVID ██% $148M -2.6x 3.3x
One World Products, Inc. OWPC ██% $920K x 0.8x
Phibro Animal Health Corp PAHC ██% $2.03B 22.1x 6.1x
Prestige Consumer Healthcare Inc. PBH ██% $3.17B 17.0x 1.7x
Psyence Biomedical Ltd. PBM ██% $3M x x
Puma Biotechnology, Inc. PBYI ██% $300M 9.7x 2.3x
Pacira Biosciences, Inc. PCRX ██% $931M 132.4x 1.3x
Processa Pharmaceuticals, Inc. PCSA ██% $7M -0.5x 1.2x
Procyon Corp PCYN ██% $980K x 0.4x
Pds Biotechnology Corp PDSB ██% $38M -1.7x 4.0x
Pepgen Inc. PEPG ██% $392M -1.6x 2.7x
Pfizer Inc PFE ██% $154.12B 19.8x 1.8x
Precigen, Inc. PGEN ██% $1.21B -1.4x 28.9x
Phathom Pharmaceuticals, Inc. PHAT ██% $766M -1.6x 43.5x
Phio Pharmaceuticals Corp. PHIO ██% $14M -0.8x 0.7x
Pharvaris N.V. PHVS ██% $1.69B x x
Protokinetix, Inc. PKTX ██% $2M x 8.6x
Plandai Biotechnology, Inc. PLPL ██% $450K x 1.5x
Pliant Therapeutics, Inc. PLRX ██% $82M -4.5x 0.4x
Polomar Health Services, Inc. PMHS ██% $4M x 0.6x
Promis Neurosciences Inc. PMN ██% $46M -2.1x 5.0x
Pmv Pharmaceuticals, Inc. PMVP ██% $85M -1.6x 0.8x
Purple Biotech Ltd. PPBT ██% $4M x x
Propanc Biopharma, Inc. PPCB ██% $3M x 0.3x
Praxis Precision Medicines, Inc. PRAX ██% $7.94B -4.0x 9.0x
Prf Technologies Ltd. PRFX ██% $2M x 0.3x
Perrigo Co Plc PRGO ██% $1.37B -27.6x 0.5x
Prelude Therapeutics Inc PRLD ██% $245M -0.5x 3.6x
Prophase Labs, Inc. PRPH ██% $620K -0.5x 0.1x
Proqr Therapeutics N.V. PRQR ██% $191M x x
Prothena Corp Public Ltd Co PRTA ██% $518M -12.4x 1.9x
Ptc Therapeutics, Inc. PTCT ██% $5.43B 8.0x 3774.6x
Protagonist Therapeutics, Inc PTGX ██% $6.05B 119.5x 9.8x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M -2.8x 1.1x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $340K -0.1x 0.1x
Pulmatrix, Inc. PULM ██% $8M -1.8x 2.1x
Provectus Biopharmaceuticals, Inc. PVCT ██% $23M x 6.7x
Palvella Therapeutics, Inc. PVLA ██% $1.96B x 50.7x
Pyxis Oncology, Inc. PYXS ██% $85M -1.3x 1.2x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $14M x 5.4x
Quantum Biopharma Ltd. QNTM ██% $11M x x
Q32 Bio Inc. QTTB ██% $85M 2.9x 2.0x
Uniqure N.V. QURE ██% $1.13B -2.8x 5.7x
Radiopharm Theranostics Ltd RADX ██% $39M x x
Rani Therapeutics Holdings, Inc. RANI ██% $166M -1.3x 83.4x
Rapport Therapeutics, Inc. RAPP ██% $1.44B x 2.8x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.15B -7.0x 234.6x
Rocket Pharmaceuticals, Inc. RCKT ██% $539M -4.8x 1.9x
Arcus Biosciences, Inc. RCUS ██% $3.08B -5.5x 4.9x
Dr Reddys Laboratories Ltd RDY ██% $12.07B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $81.65B 18.1x 2.6x
Revelation Biosciences, Inc. REVB ██% $3M -0.1x 0.4x
Rafael Holdings, Inc. RFL ██% $76M -0.9x 0.9x
Regen Biopharma Inc RGBP ██% $100K x 1.3x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $515M 1.4x 1.3x
Relmada Therapeutics, Inc. RLMD ██% $471M -0.1x 49.7x
Rallybio Corp RLYB ██% $53M -0.7x 0.8x
Retrieve Medical Holdings, Inc. RMHI ██% $60M x 793.6x
Rockwell Medical, Inc. RMTI ██% $34M -17.1x 0.9x
Avidity Biosciences, Inc. RNA ██% $230M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $216M -2.1x 287.6x
Transcode Therapeutics, Inc. RNAZ ██% $8M -0.2x 5.6x
Rein Therapeutics, Inc. RNTX ██% $31M x 0.7x
Renovorx, Inc. RNXT ██% $29M -3.4x 3.6x
Roivant Sciences Ltd. ROIV ██% $20.54B 1.8x 4.8x
Royalty Pharma Plc RPRX ██% $26.85B 34.8x 4.2x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x 6425307.7x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $15M -4.1x 3.4x
Rhythm Pharmaceuticals, Inc. RYTM ██% $6.15B -20.3x 44.2x
Rezolute, Inc. RZLT ██% $307M -3.9x 2.4x
Filana Therapeutics, Inc. SAVA ██% $115M -1.9x 1.4x
Sunshine Biopharma Inc. SBFM ██% $5M -0.6x 0.2x
Scienture Holdings, Inc. SCNX ██% $20M 2.9x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $20K 0.0x 0.0x
Scynexis Inc SCYX ██% $31M -2.4x 0.9x
Schrodinger, Inc. SDGR ██% $908M -7.8x 2.5x
Septerna, Inc. SEPN ██% $1.21B x 3.2x
Serina Therapeutics, Inc. SER ██% $16M 22.6x 9.2x
Sagimet Biosciences Inc. SGMT ██% $184M x 1.7x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $3M x 2.1x
Siga Technologies Inc SIGA ██% $383M 16.5x 1.9x
Silo Pharma, Inc. SILO ██% $5M x 1.0x
Sionna Therapeutics, Inc. SION ██% $1.70B x 5.6x
Skinvisible, Inc. SKVI ██% $2M x x
Skye Bioscience, Inc. SKYE ██% $23M -0.7x 1.2x
Sol-Gel Technologies Ltd. SLGL ██% $255M x 8.0x
Silence Therapeutics Plc SLN ██% $328M x 5.3x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.07B 99.1x 4.6x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $934M -1.0x 20.5x
Summit Therapeutics Inc. SMMT ██% $12.75B 104.1x 19.4x
Syndax Pharmaceuticals Inc SNDX ██% $2.11B -4.1x 32.7x
Soligenix, Inc. SNGX ██% $13M -1.8x 1.7x
Sibannac, Inc. SNNC ██% $1M x 2.3x
Sensei Biotherapeutics, Inc. SNSE ██% $37M -0.4x 1.6x
Sanofi SNY ██% $106.41B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $69M -0.4x 1.6x
Scisparc Ltd. SPRC ██% $2M x x
Spero Therapeutics, Inc. SPRO ██% $130M -17.8x 4.9x
Ars Pharmaceuticals, Inc. SPRY ██% $855M -23.5x 7.5x
Sarepta Therapeutics, Inc. SRPT ██% $1.79B 162.5x 1.6x
Stoke Therapeutics, Inc. STOK ██% $2.06B 50.9x 6.7x
Shattuck Labs, Inc. STTK ██% $373M x 4.5x
Supernus Pharmaceuticals, Inc. SUPN ██% $3.10B 46.0x 2.9x
Savara Inc SVRA ██% $1.11B -8.2x 11.8x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M -0.6x 0.8x
Synlogic, Inc. SYBX ██% $7M 3.6x 0.7x
Spyre Therapeutics, Inc. SYRE ██% $3.24B -0.7x 4.5x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $56.49B x x
Theravance Biopharma, Inc. TBPH ██% $688M 23.4x 3.0x
Alaunos Therapeutics, Inc. TCRT ██% $8M -1.0x 2.7x
Telomir Pharmaceuticals, Inc. TELO ██% $48M x 6.9x
Tenax Therapeutics, Inc. TENX ██% $85M -14.9x 0.9x
Terns Pharmaceuticals, Inc. TERN ██% $4.66B -5.1x 16.4x
Teva Pharmaceutical Industries Ltd TEVA ██% $35.36B 25.1x 4.5x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $4.41B 9.9x 6.8x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $41M -2.3x 2.1x
Telix Pharmaceuticals Ltd TLX ██% $2.60B x x
Tango Therapeutics, Inc. TNGX ██% $2.32B -2.8x 6.7x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $178M 0.0x 0.8x
Theriva Biologics, Inc. TOVX ██% $6M -0.4x 0.1x
Tempest Therapeutics, Inc. TPST ██% $32M -0.5x 5.1x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $511M 6.9x 1.7x
Trevi Therapeutics, Inc. TRVI ██% $1.71B -6.1x 9.0x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Tvardi Therapeutics, Inc. TVRD ██% $35M x 1.3x
Travere Therapeutics, Inc. TVTX ██% $2.54B x 22.2x
Therapeuticsmd, Inc. TXMD ██% $26M 527.8x 1.0x
Tyra Biosciences, Inc. TYRA ██% $1.92B -9.5x 7.4x
Unicycive Therapeutics, Inc. UNCY ██% $147M -0.9x 3.9x
Upstream Bio, Inc. UPB ██% $495M x 1.3x
Urogen Pharma Ltd. URGN ██% $907M -2.5x 35.5x
United Therapeutics Corp UTHR ██% $23.59B 17.7x 3.3x
Vaccinex, Inc. VCNX ██% $2M -0.1x 0.2x
Vera Therapeutics, Inc. VERA ██% $2.70B -20.4x 4.5x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vicapsys Life Sciences, Inc. VICP ██% $49M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $4.11B -67.5x 6.4x
Vanda Pharmaceuticals Inc. VNDA ██% $547M -16.1x 1.7x
Verrica Pharmaceuticals Inc. VRCA ██% $100M -0.5x 4.0x
Viridian Therapeutics, Inc.\De VRDN ██% $2.97B -4.5x 4.1x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $116.00B 29.3x 6.2x
Verastem, Inc. VSTM ██% $481M -6.5x 8.4x
Vistagen Therapeutics, Inc. VTGN ██% $22M -0.1x 0.4x
Viatris Inc VTRS ██% $16.44B -29.5x 0.0x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $20M -0.4x 0.7x
Whitehawk Therapeutics, Inc. WHWK ██% $189M x 1.2x
Wave Life Sciences Ltd. WVE ██% $2.64B -22.2x 5.1x
Xenetic Biosciences, Inc. XBIO ██% $6M x 1.5x
Xbiotech Inc. XBIT ██% $71M -3.5x 0.4x
Exicure, Inc. XCUR ██% $26M -1.9x 3.8x
Xenon Pharmaceuticals Inc. XENE ██% $4.72B -15.4x 8.1x
Xeris Biopharma Holdings, Inc. XERS ██% $966M 1743.2x 70.6x
Xilio Therapeutics, Inc. XLO ██% $40M -0.5x 5.6x
Xencor Inc XNCR ██% $865M -8.4x 1.4x
Xoma Royalty Corp XOMA ██% $332M 15.3x 3.8x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.36B x 6.9x
Zai Lab Ltd ZLAB ██% $2.11B -95.2x 3.0x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $149M -1.4x 0.6x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $50.90B 19.0x 15.3x
Zevra Therapeutics, Inc. ZVRA ██% $592M 7.1x 3.8x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x 0.4x
Zymeworks Inc. ZYME ██% $1.88B -8.3x 7.0x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Teva Pharmaceutical Industries Ltd Stock Forecast

How accurate are Teva Pharmaceutical Industries Ltd stock predictions?

Our AI model shows a 4% Spearman correlation coefficient for TEVA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Teva Pharmaceutical Industries Ltd stock price forecasts?

Our analysis considers Teva Pharmaceutical Industries Ltd's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Teva Pharmaceutical Industries Ltd a good investment in 2025?

Based on our AI analysis, Teva Pharmaceutical Industries Ltd shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Teva Pharmaceutical Industries Ltd forecasts updated?

Teva Pharmaceutical Industries Ltd stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...